Table 1.
Antibiotic | Pharmacokinetic model | AutoKinetics dosing target | Routine practice at Amsterdam UMC, location VUmc | Routine practice at OLVG Oost |
---|---|---|---|---|
Ceftriaxone | Garot et al., 2011 [19] | 100%T > 4 × MIC | 2000mg every 24 h | 2000mg every 24 h |
Meropenem | Muro et al., 2011 [20] | 100%T > 4 × MIC | 1000mg every 8 h | 1000mg every 8 h |
Ciprofloxacin | Khachman et al., 2011 [21] | AUC0–24/MIC > 125 | 400mg every 8 h | 400mg every 12 h |
Vancomycin | Roberts al., 2011 [22] | AUC0–24/MIC > 400 | 1000mg every 24 h + TDM | 1000mg every 24 h + TDM |
Pharmacometric models, dosing targets and routine dosing for the study antibiotics. All model parameters were calibrated prior to implementation. For meropenem and ciprofloxacin, routine dosing includes a dose reduction by 50% and an increased dosing interval to 2dd if the estimated glomerular filtration rate is less than 30 ml/min/1.73 m2. For vancomycin, routine dosing includes dose adaptation using therapeutic drug monitoring after 1–3 days at Amsterdam UMC, location VUmc and after every 24 h at OLVG Oost. Vancomycin is administered by continuous infusion at OLVG Oost
AUC area under the time–concentration curve, MIC minimal inhibitory concentration, TDM therapeutic drug monitoring, 100%T hundred percent of time